1. Home
  2. JAGX vs AEMD Comparison

JAGX vs AEMD Comparison

Compare JAGX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • AEMD
  • Stock Information
  • Founded
  • JAGX 2013
  • AEMD 1984
  • Country
  • JAGX United States
  • AEMD United States
  • Employees
  • JAGX N/A
  • AEMD 9
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • AEMD Medical/Dental Instruments
  • Sector
  • JAGX Health Care
  • AEMD Health Care
  • Exchange
  • JAGX Nasdaq
  • AEMD Nasdaq
  • Market Cap
  • JAGX 3.9M
  • AEMD 3.4M
  • IPO Year
  • JAGX N/A
  • AEMD N/A
  • Fundamental
  • Price
  • JAGX $1.71
  • AEMD $4.25
  • Analyst Decision
  • JAGX Strong Buy
  • AEMD Buy
  • Analyst Count
  • JAGX 1
  • AEMD 2
  • Target Price
  • JAGX $60.00
  • AEMD $287.50
  • AVG Volume (30 Days)
  • JAGX 114.8K
  • AEMD 54.6K
  • Earning Date
  • JAGX 11-14-2025
  • AEMD 11-13-2025
  • Dividend Yield
  • JAGX N/A
  • AEMD N/A
  • EPS Growth
  • JAGX N/A
  • AEMD N/A
  • EPS
  • JAGX N/A
  • AEMD N/A
  • Revenue
  • JAGX $11,810,000.00
  • AEMD N/A
  • Revenue This Year
  • JAGX $22.41
  • AEMD N/A
  • Revenue Next Year
  • JAGX $30.00
  • AEMD N/A
  • P/E Ratio
  • JAGX N/A
  • AEMD N/A
  • Revenue Growth
  • JAGX 15.96
  • AEMD N/A
  • 52 Week Low
  • JAGX $1.57
  • AEMD $4.33
  • 52 Week High
  • JAGX $33.25
  • AEMD $84.40
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 36.00
  • AEMD 60.30
  • Support Level
  • JAGX $1.77
  • AEMD $5.05
  • Resistance Level
  • JAGX $2.00
  • AEMD $5.89
  • Average True Range (ATR)
  • JAGX 0.13
  • AEMD 0.42
  • MACD
  • JAGX -0.04
  • AEMD -0.09
  • Stochastic Oscillator
  • JAGX 9.09
  • AEMD 1.92

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: